These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1126572)

  • 1. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic and virologic aspects of secretory immune system in human respiratory tract.
    Ogra PL; Morag A
    Dev Biol Stand; 1975; 28():129-44. PubMed ID: 47823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to influenza virus in rabbits after local immunization. II. Local and systemic cell mediated response.
    Kasturi K; Hannoun C
    Ann Microbiol (Paris); 1977 Apr; 128A(3):349-64. PubMed ID: 921142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response to influenza vaccines.
    Ghendon Y
    Acta Virol; 1990 May; 34(3):295-304. PubMed ID: 1980401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
    Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
    Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
    Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
    Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keeping the memory of influenza viruses.
    Combadière B; Sibéril S; Duffy D
    Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D; Ogra PL
    Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems of specific cellular immunity against influenza].
    Shvartsman IaS; Ispolatova AV; Tsybul'skaia NV
    Usp Sovrem Biol; 1979; 88(1):77-92. PubMed ID: 388905
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.
    Couch RB
    Dev Biol Stand; 1975; 28():295-306. PubMed ID: 1126573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of specific in vitro antibody production following influenza immunization.
    Mitchell DM; Fitzharris P; Knight RA; Schild GC
    Clin Exp Immunol; 1982 May; 48(2):491-8. PubMed ID: 7105493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.